淋巴细胞/单核细胞比值对恶性肿瘤患者预后评估的研究进展

doi:10.11904/j.issn.1002-3070.2017.02.019

Abstract

Abstract: Inflammation has a critical role in the pathogenesis and progression of cancer.lymphocyte and monocyte play an important role in inflammatory reaction,reflecting body immune status.In recent years,more and more clinical studies have shown that pretreatment of lymphocyte-to-monocyte ratio(LMR)in the patients with malignant tumor may have a certain value in evaluating the prognosis of cancer patients such as nasopharyngeal cancer,esophageal cancer,breast cancer,ovarian cancer,lung cancer,gastric cancer,colorectal cancer,etc.This article reviews the latest research progress on the value of LMR in the evaluation of the prognosis of the patients with malignant tumor.

Key words: Lymphocyte-to-monocyte ratio, Tumors, Prognosis, Inflammatory factor

CLC Number:

ZHANG Aiqi,JIN Shi,CAO Shoubo,YU Yan. Prognostic value of lymphocyte-to-monocyte ratio in the patients with malignant tumor[J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(2): 188-192.

References

1 Deng Q,He B,Liu X,et al.Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model[J].J Transl Med,2015,13(1):66-81.
2 Li J,Lin J,Luo Y,et al.Multivariate analysis of prognostic biomarkers in surgically treated endomertial cancer[J].PLoS One,2015,10(6):e0130640.
3 Hasenclever D,Diehl V.A prognostic score for advanced Hodgkin′s disease.International Prognostic Factors Project on Advanced Hodgkin′s Disease[J].N Engl J Med,1998,339(21):1506-1514.
4 Ray-Coquard I,Cropet C,Van Glabbeke M,et al.Lymphopenia as a prognostic factor for overall survival in advanced carcinomas,sarcomas,and lymphomas[J].Cancer Res,2009,69(13):5383-5391.
5 Ceze N,Thibault G,Goujon G,et al.Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy[J].Cancer Chemother Pharmacol,2011,68(5):1305-1313.
6 Chanmee T,Ontong P,Konno K,et al.Tumor-associated macrophages as major players in the tumor microenvironment[J].Cancers(Basel),2014,6(3):1670-1690.
7 Schmidt H,Bastholt L,Geertsen P,et al.Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma:a prognostic model[J].Br J Cancer,2005,93(3):273-278.
8 Lee YY,Choi CH,Sung CO,et al.Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer:comparison with SCC-Ag level[J].Gynecol Oncol,2012,124(1):92-97.
9 Koh YW,Shin SJ,Park C,et al.Absolute monocyte count predicts overall survival in mantle cell lymphomas:correlation with tumour-associated macrophages[J].Hematol Oncol,2014,32(4):178-186.
10 Li ZM,Huang JJ,Xia Y,et al.Blood lymphocyte-tomonocyteratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP[J].PLoS One,2012,7(7):e41658.
11 Porrata LF,Ristow K,Colgan JP,et al.Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin′s lymphoma[J].Haematologica,2012,97(2):262-269.
12 Man YG,Stojadinovic A,Mason J,et al.Tumor-infiltrating immune cells promoting tumor invasion and metastasis:existingtheories[J].J Cancer,2013,4(1):84-95.
13 Tsutsui S,Yasuda K,Suzuki K,et al.Macrophage infiltration and its prognostic implications in breast cancer:the relationshipwith VEGF expression and microvessel density[J].Oncol Rep,2005,14(2):425-431.
14 Steidl C,Lee T,Shah SP,et al.Tumor-associated macrophages and survival in classic Hodgkin′s lymphoma[J].N Engl J Med,2010,362(10):875-885.
15 Liao Q,Zeng Z,Guo X,et al.LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation[J].Oncogene,2014,33(16),2098-2109.
16 Liao Q,Guo X,Li X,et al.Analysis of the contribution of nasopharyngeal epithelial cancer cells to the induction of a local inflammatory response[J].J Cancer Res Clin Oncol,2011,138(1):57-64.
17 Li J,Jiang R,Liu WS,et al.A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma[J].PLoS One,2013,8(12):e83069.
18 Lin GN,Peng JW,Liu DY,et al.Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy[J].Tumor Biology,2014,35(11):10849-10854.
19 Ni XJ,Zhang XL,Ou-Yang QW,et al.An elevated peripheral blood lymphocyte-to-monocyte ratio predicts favorable response and prognosis in locally advanced breast cancer following neoadjuvant chemotherapy[J].PLoS One,2014,9(11):e111886.
20 吴朔,姜翠,徐君南,等.淋巴细胞/单核细胞比值在三阴性乳腺癌预后评估中的临床研究[J].现代预防医学,2016,43(15):2855-2858.
21 王秀娟,苑中甫,邱海峰,等.术前外周血淋巴细胞/单核细胞比值与上皮性卵巢癌患者预后的关系[J].现代妇产科进展,2016,9(25):654-657.
22 Hu P,Shen H,Wang G,et al.Prognostic significance of systemic inflammation-based lymphocyte-monocyte ratio in patients with lung cancer:based on a large cohort study[J].PLoS One,2014,9(9):e108062.
23 Go SI,Kim RB,Song HN,et al.Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer[J].Med Oncol,2014.31(12):323-329.
24 Heinemann V,von Weikersthal LF,Decker T,et al.FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer(FIRE-3):a randomised,open-label,phase 3 trial[J].Lancet Oncol 2014,15(10):1065-1075.
25 Grothey A,Sugrue MM,Purdie DM,et al.Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer:results from a large observational cohort study(BRiTE)[J].J Clin Oncol,2008,26(33):5326-5334.
26 Shibutani M,Maeda K,Nagahara H,et al.Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer[J].World J Gastroenterol,2015,21(34):9966-9973.
27 Fong Y,Fortner J,Sun RL,et al.Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer:analysis of 1001 consecutive cases[J].Ann Surg,1999,230(3):309-321.
28 John SK,Robinson SM,Rehman S,et al.Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy:an 11-year single-centre study[J].Dig Surg,2013,30(4-6):293-301.
29 Tomlinson JS,Jarnagin WR,DeMatteo RP,et al.Actual 10-year survival after resection of colorectal liver metastases defines cure[J].J Clin Oncol,2007,25(29):4575-4580.
30 Neofytou K,Smyth EC,Giakoustidis A,et al.The preoperative lymphocyte-to-monocyte ratio is prognostic of clinical outcomes for patients with liver-only colorectal metastases in the neoadjuvant setting[J].Ann Surg Oncol,2015,22(13):4353-4362.

[1]	WANG Xiaoya,XIAO Bin,LIAO Yang,TANG Rongzhi,SUN Zhaohui,LI Linhai. Expression of CXCR family proteins in different subtypes of breast cancer and their clinical prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 206-210.
[2]	FENG Yue,XING Linan,WANG Zhao,ZHANG Yunyan. Correlation between NLR and prognosis of concurrent chemoradiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 284-288.
[3]	BAI Xiaobin, HUO Longwei, XIE Wanfu, XU Gaofeng, WANG Maode. Expression of Chk1 in glioblastoma and its association with tumor biological behavior and prognosis survival [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 122-127.
[4]	SHI Xiaokang, DING Youming, WANG Bin, YU Bin, XU Yu. Expression and clinical significance of UBE2T in primary liver cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 128-133.
[5]	LU Jiaoyun, ZHANG Qingyuan. Advances in laboratory markers in the prognosis of diffuse large B-cell lymphoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 183-187.
[6]	ZHAO Fengjuan, WANG Qi, REN Yunhong, WEI Jueling, LI Lequn, ZHAO Xinhua, TANG Juan, YOU Xuemei. Changes of serum CRP and hs-CRP levels in patients with liver cancer and depression and their influence on prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 27-33.
[7]	ZHANG Fengchun, JIANG Ying, LIU Zhaonan, YAN Ningning, CUI Hongquan, XU Yingchun. Prognostic significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in systemic inflammation-related indicators in gastric cancer patients after radical resection [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 34-39.
[8]	MA Jianli, ZHANG Minghui, JI Hongfei, XU Xiangying. Clinical significance of combined detection of PD-L1 protein and CD8⁺TILs in resected lung adenocarcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 40-46.
[9]	YANG Hongbo, SHI Jie, YE Yong, LI Wencheng, DENG Zhaoping. Expression of COL5A2 in bladder cancer tissues and its correlation with clinicopathological features and prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 52-56.
[10]	DING Jiexian, ZHANG Jin, CHEN Yonggang, WANG Xingwen, WANG Shuanke. Progress in Wnt signaling pathway and tumorigenesis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 73-77.
[11]	WANG Yalong, LYU Zhangyan, ZHANG Fan, FENG Xiaoshuang, WEI Luopei, LI Xin, WEN Yan, GAO Yushun, XUE Qi, GAO Shugeng, TAN Fengwei. Relationship between human papillomavirus infection and prognosis of lung cancer:A meta-analysis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 520-526.
[12]	TANG Shuli, HE Kuangbang, ZHANG Chunhui, CHENG Jianan, ZHANG Yanqiao. Expression of miR-320a and CYLD in gastric cancer and its relationship with clinicopathological characteristics and prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 538-544.
[13]	XIAO Hongwei, CHEN Sheng, WANG Yanliang, SU Xueliang. The prognostic and influence factors analysis of transanal local resection for stage T₁ rectal cancer with the distance from anal margin ≤8 cm [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 545-549.
[14]	LIU Juan, ZHANG Shutian. Advances in research on the mechanism of cyclin-dependent kinase inhibitor 3(CDKN3)in tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 575-578.
[15]	WANG Yiran, HUANG Wei, YIN Lei, LIU Lin, ZHOU Xiaoping, NIU Xingjian, YANG Yue, AN Weiwei, JI Hongfei. The ratio of neutrophil to lymphocyte in the efficacy and prognosis of concurrent chemoradiotherapy in patients with cervical cancer and its clinical significance [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 404-409.

Prognostic value of lymphocyte-to-monocyte ratio in the patients with malignant tumor

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments